Decentralised manufacturing of cell and gene therapy products: learning from other healthcare sectors
Decentralised or 'redistributed' manufacturing represents an attractive choice for production of some cell and gene therapies (CGTs), in particular personalised therapies. Decentralised manufacturing splits production into various locations or regions and in doing so, imposes organisationa...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Default Article |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/28186 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|